These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3142778)
1. Application of recombinant granulocyte-macrophage colony-stimulating factor has a detrimental effect in experimental murine leishmaniasis. Greil J; Bodendorfer B; Röllinghoff M; Solbach W Eur J Immunol; 1988 Oct; 18(10):1527-33. PubMed ID: 3142778 [TBL] [Abstract][Full Text] [Related]
2. GM-CSF produced by recombinant vaccinia virus or in GM-CSF transgenic mice has no effect in vivo on murine cutaneous leishmaniasis. Corcoran LM; Metcalf D; Edwards SJ; Handman E J Parasitol; 1988 Oct; 74(5):763-7. PubMed ID: 3047351 [TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor. Gajewski TF; Goldwasser E; Fitch FW J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726 [TBL] [Abstract][Full Text] [Related]
4. Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation. Blazar BR; Widmer MB; Kersey JH; Ramsay NK; McGlave PB; Urdal DL; Gillis S; Henney C; Vallera DA Behring Inst Mitt; 1988 Aug; (83):170-80. PubMed ID: 3071335 [TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice. Tanikawa S; Nakao I; Tsuneoka K; Nara N Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360 [TBL] [Abstract][Full Text] [Related]
6. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor. Falk LA; Wahl LM; Vogel SN J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601 [TBL] [Abstract][Full Text] [Related]
7. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804 [TBL] [Abstract][Full Text] [Related]
8. The therapeutic effect of human recombinant macrophage colony stimulating factor (CSF-1) in experimental murine metastatic melanoma. Hume DA; Donahue RE; Fidler IJ Lymphokine Res; 1989; 8(1):69-77. PubMed ID: 2654493 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the growth of IL-3-dependent mast cells from murine bone marrow by recombinant granulocyte macrophage-colony-stimulating factor. Bressler RB; Thompson HL; Keffer JM; Metcalfe DD J Immunol; 1989 Jul; 143(1):135-9. PubMed ID: 2471732 [TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401 [TBL] [Abstract][Full Text] [Related]
12. Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages. Handman E; Burgess AW J Immunol; 1979 Mar; 122(3):1134-7. PubMed ID: 312818 [TBL] [Abstract][Full Text] [Related]
13. Interactions between purified murine colony-stimulating factors (natural CSF-1, recombinant GM-CSF, and recombinant IL-3) on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells. Williams DE; Straneva JE; Cooper S; Shadduck RK; Waheed A; Gillis S; Urdal D; Broxmeyer HE Exp Hematol; 1987 Nov; 15(10):1007-12. PubMed ID: 3311784 [TBL] [Abstract][Full Text] [Related]
14. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. Fu YX; Watson GA; Kasahara M; Lopez DM J Immunol; 1991 Jan; 146(2):783-9. PubMed ID: 1824777 [TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant murine granulocyte-macrophage colony-stimulating factor in cyclophosphamide-treated mice. Gamba-Vitalo C; DiGiovanna MP; Sartorelli AC Blood Cells; 1991; 17(1):193-205; discussion 206-8. PubMed ID: 2018856 [TBL] [Abstract][Full Text] [Related]
16. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E. Hancock WW; Pleau ME; Kobzik L J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507 [TBL] [Abstract][Full Text] [Related]
17. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells. Ferret-Bernard S; Saï P; Bach JM Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293 [TBL] [Abstract][Full Text] [Related]
18. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. Sadick MD; Locksley RM; Tubbs C; Raff HV J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789 [TBL] [Abstract][Full Text] [Related]
19. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. Neta R; Oppenheim JJ; Douches SD J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166 [TBL] [Abstract][Full Text] [Related]
20. Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3. Feng ZY; Louis J; Kindler V; Pedrazzini T; Eliason JF; Behin R; Vassalli P Eur J Immunol; 1988 Aug; 18(8):1245-51. PubMed ID: 2970970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]